The single-chain variable fragment (scFv) portion of the CAR was directed against three different target antigens present on normal myeloid precursors and most AML: CD33, CD123, and CD117 (Figs. 1A and EV1A). This evidence concerns the gene CD33 and acute myeloid leukemia.